首页> 外文期刊>Journal of the Formosan Medical Association =: Taiwan yi zhi >Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?
【24h】

Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?

机译:哪一个,胃部椎管细胞抗体阳性或高管症是一种更好的生物标志物,以预测口腔粘膜病患者的维生素B12缺乏症?

获取原文
           

摘要

The gastric parietal cell antibody (GPCA) is an autoantibody that can destroy gastric parietal cells, resulting in lack of intrinsic factors. 1e3 Intrinsic factor deficiency may lead to malabsorption of vitamin B12 from terminal ileum and finally the vitamin B12 deficiency. 1e5 However, other con- ditions including inadequate intake, food-bound vitamin B12 malabsorption, the presence of intrinsic factor anti- body in sera of patients, ileal malabsorption in patients with enteritis or ileal resection, biologic competition including bacterial overgrowth and tapeworm infestation, and defective transport such as transcobalamin II defi- ciency may also cause the vitamin B12 deficiency.
机译:胃榫蚀细胞抗体(GPCA)是一种可破坏胃部细胞的自身抗体,导致缺乏内在因素。 1E3内在因子缺乏可能导致来自inerum末端的维生素B12的恶化,并且最后维生素B12缺乏。然而,其他共同包括摄入不足,食物腺体维生素B12不良吸收性,患者血清中的内在因子抗体的存在,肠炎或肠道切除患者的嗜睡剂,生物竞争包括细菌过度生殖和绦虫侵扰,诸如转基钴胺II级效率的缺陷的交通也可能导致维生素B12缺乏症。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号